BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37749865)

  • 21. PBRM1 deficiency oncogenic addiction is associated with activated AKT-mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells.
    Tang Y; Jin YH; Li HL; Xin H; Chen JD; Li XY; Pan YF
    J Cell Mol Med; 2022 Jul; 26(14):3837-3849. PubMed ID: 35672925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling.
    Feng Q; Cheng M; Jin J; Zhang S; Bai Y; Xu J
    Acta Histochem; 2022 Apr; 124(3):151874. PubMed ID: 35299128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of homeobox D10 expression suppresses invasion and migration of clear cell renal cell carcinoma through targeting of E-cadherin.
    Ren Z; Niu Y; Fan B; Zhang A
    Mol Biol Rep; 2022 Mar; 49(3):1837-1846. PubMed ID: 34825321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamin A/C Acts as an Essential Factor in Mesenchymal Stem Cell Differentiation Through the Regulation of the Dynamics of the Wnt/β-Catenin Pathway.
    Bermeo S; Vidal C; Zhou H; Duque G
    J Cell Biochem; 2015 Oct; 116(10):2344-53. PubMed ID: 25846419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma.
    Wu F; Wu S; Tong H; He W; Gou X
    Int J Oncol; 2019 Jun; 54(6):2095-2105. PubMed ID: 31081053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ESM-1 Mediates Cell Progression in Clear Cell Renal Cell Carcinoma by Affecting Wnt/β-Catenin Signalling Pathway.
    Liu X; Wang F; Du W; Yang X
    Arch Esp Urol; 2023 Jun; 76(4):290-297. PubMed ID: 37455528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
    Kulkarni P; Dasgupta P; Hashimoto Y; Shiina M; Shahryari V; Tabatabai ZL; Yamamura S; Tanaka Y; Saini S; Dahiya R; Majid S
    Cancer Res; 2021 Mar; 81(6):1500-1512. PubMed ID: 33500248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression.
    Ji J; Xu Y; Xie M; He X; Ren D; Qiu T; Liu W; Chen Z; Shi W; Zhang Z; Wang X; Wang W; Ma J; Qian Q; Jing A; Ma X; Qin J; Ding Y; Geng T; Yang J; Sun Z; Liu W; Liu S; Liu B
    Cell Death Dis; 2023 Feb; 14(2):83. PubMed ID: 36739418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma.
    Jiangqiao Z; Tao Q; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z; Tianyu W
    Biochem Biophys Res Commun; 2019 Mar; 511(1):165-172. PubMed ID: 30777326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
    Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
    Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
    Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
    Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.
    Liu T; Xiang W; Chen Z; Wang G; Cao R; Zhou F; Meng Z; Luo Y; Chen L
    Cell Death Dis; 2023 Nov; 14(11):774. PubMed ID: 38008826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
    Chen W; Niu S; Ma X; Zhang P; Gao Y; Fan Y; Pang H; Gong H; Shen D; Gu L; Zhang Y; Zhang X
    PLoS One; 2016; 11(7):e0157599. PubMed ID: 27384222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β-catenin and PI3K/AKT signaling pathways.
    Zhang LN; Zhao L; Yan XL; Huang YH
    J Cell Physiol; 2019 Nov; 234(11):20469-20484. PubMed ID: 30989663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
    Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma.
    Wang Y; Dong D; Jiang S; Zhang E; Zheng W; Mao L; Li W; Zhou J; Fan L; Cheng R; Li Z; Fang Z; Gui Y; Li X
    Cell Physiol Biochem; 2018; 49(5):1755-1765. PubMed ID: 30231239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of stearoyl-coenzyme A desaturase 1 in clear cell renal cell carcinoma.
    Wang H; Zhang Y; Lu Y; Song J; Huang M; Zhang J; Huang Y
    Tumour Biol; 2016 Jan; 37(1):479-89. PubMed ID: 26224474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ellagic acid inhibits cell proliferation, migration, and invasion of anaplastic thyroid cancer cells via the Wnt/β-catenin and PI3K/Akt pathways.
    Meng X; Cui Z; Shi H; Ma X; Li W; Liu X; Jiang Y
    Acta Biochim Pol; 2023 Feb; 70(1):109-115. PubMed ID: 36773307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.